| 项目编号 | PRJCA036922 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 项目标题 | Circulating tumor DNA analysis from the Evidence trail | ||||||||
| 涉及领域 | Medical | ||||||||
| 数据类型 | Raw sequence reads | ||||||||
| 物种名称 | Homo sapiens | ||||||||
| 描述信息 | The EVIDENCE was a phase 3, multicenter, randomized, open-label trial conducted in China (NCT02448797). This post-hoc minimal residual disease (MRD) analysis of the EVIDENCE study aimed to evaluate the prognostic and monitoring utility of ctDNA-based MRD in early-stage, resected EGFR-mutated NSCLC patients receiving adjuvant therapy. | ||||||||
| 样品范围 | Multiisolate | ||||||||
| 发布日期 | 2025-12-01 | ||||||||
| 项目资金来源 |
|
||||||||
| 提交者 | Fei Zhou (fei.zhou@tongji.edu.cn) | ||||||||
| 提交单位 | Shanghai East Hospital | ||||||||
| 提交日期 | 2025-03-05 |
| 资源名称 | 描述 |
|---|---|
| BioSample (1702) show | - |